Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIV-1 Infected Adults
Completed · Phase 3 · Has a placebo group
Conditions studied: HIV-1 Infection
In brief
The primary objective of this study is to evaluate the non-inferiority of switching to emtricitabine/rilpivirine/tenofovir alafenamide (FTC/RPV/TAF) fixed dose combination (FDC) as compared to continuing the non-nucleoside reverse transcriptase inhibitor (NNRTI) regimen of efavirenz /FTC/tenofovir disoproxil fumarate (EFV/FTC/TDF) FDC in virologically-suppressed HIV-1 infected participants.
Key facts
- Study ID
- NCT02345226
- Run by
- Gilead Sciences
- People needed
- 881
- Starts
- 2015-01-26
- Expected to finish
- 2019-01-02
- Last updated by the study team
- 2020-01-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Spectrum Medical Group — Phoenix, Arizona, United States
- AHF Research Center — Beverly Hills, California, United States
- Pacific Oaks Medical Group — Beverly Hills, California, United States
- Long Beach Education and Research Consultants — Long Beach, California, United States
- Kaiser Permanente — Los Angeles, California, United States
- Southern California Men's Medical Group — Los Angeles, California, United States
- Tarrant County ID Associates — Los Angeles, California, United States
- Kaiser Permanente — Sacramento, California, United States
- University of California-UC Davis — Sacramento, California, United States
- La Playa Medical Group and Clinical Research — San Diego, California, United States
- Kaiser Permanente — San Francisco, California, United States
- Optimus Medical — San Francisco, California, United States
- Kaiser Permanente — San Leandro, California, United States
- Los Angeles BioMedical Institute at Harbor-UCLA Medical Center — Torrance, California, United States
- University of Colorado — Aurora, Colorado, United States
- Apex Research Institute — Denver, Colorado, United States
- Yale University School of Medicine — New Haven, Connecticut, United States
- World Health Clinicians' CIRCLE CARE Center — Norwalk, Connecticut, United States
- Capital Medical Associates, P.C. — Washington D.C., District of Columbia, United States
- Medical Faculty Associates, Inc. — Washington D.C., District of Columbia, United States
- Whitman Walker Clinic — Washington D.C., District of Columbia, United States
- Gary Richmond, MD, PA, Inc. — Fort Lauderdale, Florida, United States
- Therafirst Medical Centers — Fort Lauderdale, Florida, United States
- Midway Immunology & Research Center, LLC — Ft. Pierce, Florida, United States
- Maricopa Integrated Health System — Phoenix, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.